The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Pricing

Comparing prices across jurisdictions without misleading yourself

Solved Wiki
Solved by t.pereira in post #4
Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

Jump to the accepted answer →

L
LeitermanTL3Regular23 May 2026#1

Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable.

A coverage question with the paperwork detail included, since that is what determines the answer.

Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which is the useful thing about a well-written denial.

Before I spend a week on it: is my reading of the stated criterion correct, and is there a documented precedent for this specific ground?

2 likes 2mo
CG
c.grimaldiTL2 Moderator24 May 2026#2

Picking up the opening post: that is the part I would want checked first.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

0 likes 2mo
FV
f.villalobosTL2 Moderator24 May 2026#3
Leiterman, post #1: Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to… Go to post

On the opening post — agreed on the reasoning, with one qualification.

Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ.

21 likes in reply to #1 2mo
TP
t.pereiraTL2 Moderator Solution25 May 2026#4
f.villalobos, post #3: On the opening post — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually… Go to post
Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by revision_history on 8 Jul 2026.
  • 8 Jul 2026 — revision_history: Restructured into sections so the outline is navigable.
Editors: KTurkington, y.mensah, chromatogram, revision_history

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

9 likes in reply to #3 2mo
OO
orbitrap_olaTL3Mass spectrometrist25 May 2026#5

Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters.

0 likes 2mo
NK
n.kuuselaTL2 Moderator26 May 2026#6

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

29 likes 2mo
PW
PharmNotes_WhitfieldTL426 May 2026#7
JF
j.fonsecaTL2 Moderator26 May 2026#8
Leiterman, post #1: Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to… Go to post

post #7 is right about the mechanism and I think understates the practical bit.

Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers.

5 likes in reply to #1 2mo
KC
k.chukwuTL2 Moderator27 May 2026#9

Coming back to post #7, because the follow-up matters more than the original answer.

Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.

5 likes 2mo
AT
apostille_traceTL1Member27 May 2026#10
f.villalobos, post #3: On the opening post — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually… Go to post

Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.

0 likes in reply to #3 2mo
HS
hana.satoTL4 Moderator27 May 2026#11
n.kuusela, post #6: I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient. Go to post

Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These have eligibility restrictions but can save money.

0 likes in reply to #6 2mo
CO
c.ostergaardTL2 Moderator28 May 2026#12

Coming back to post #10, because the follow-up matters more than the original answer.

Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow.

1 like 2mo
EP
e.piresTL228 May 2026#13
FA
f.amankwahTL2 Moderator28 May 2026#14
orbitrap_ola, post #5: Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters. Go to post

Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These have eligibility restrictions but can save money.

17 likes in reply to #5 2mo
TW
t.wojcikTL2 Moderator29 May 2026#15
apostille_trace, post #10: Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live. Go to post

This follows post #12 rather than contradicting it.

Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow.

0 likes in reply to #10 2mo
AK
a.kowalskiTL2 Moderator29 May 2026#16

I read post #14 twice before replying, because I had assumed the opposite.

Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters.

0 likes 2mo
VB
v.bhattacharyaTL2 Moderator29 May 2026 · edited#17

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

4 likes 2mo
JD
j.dahlbergTL2 Moderator30 May 2026#18

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

12 likes 2mo
MY
m.yilmazTL2 Moderator30 May 2026#19
t.wojcik, post #15: This follows post #12 rather than contradicting it. Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow. Go to post

Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ.

25 likes in reply to #15 2mo
SD
s.duarteTL2 Moderator30 May 2026#20
Leiterman, post #1: Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to… Go to post

Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.

0 likes in reply to #1 2mo
MD
m.dumitruTL2 Moderator31 May 2026#21

Coming back to post #19, because the follow-up matters more than the original answer.

List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays.

0 likes 2mo
W
WickramasingheTL231 May 2026#22
DN
d.ndiayeTL2 Moderator31 May 2026 · edited#23
m.dumitru, post #21: Coming back to post #19, because the follow-up matters more than the original answer. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays. Go to post

Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.

6 likes in reply to #21 2mo
LA
l.aaltonenTL3Regular31 May 2026#24

post #23 answers the question as asked. The question underneath it is different.

Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers.

1 like 2mo
BN
b.nwosuTL2 Moderator1 Jun 2026#25

International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations.

0 likes 2mo
BP
baseline_peakTL2Member1 Jun 2026#26

Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.

30 likes 2mo
BJ
b.jansenTL2 Moderator1 Jun 2026#27
Leiterman, post #1: Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to… Go to post

Worth separating two things that post #23 runs together.

International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations.

10 likes in reply to #1 2mo
Z
ZieglerTL3Regular2 Jun 2026#28
Wickramasinghe, post #22: For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

post #27 is right about the mechanism and I think understates the practical bit.

Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers.

3 likes in reply to #22 2mo
ID
i.dumitruTL2 Moderator2 Jun 2026#29

Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters.

1 like 2mo
R
RidgewayTL3Regular2 Jun 2026#30

Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow.

0 likes 2mo